INOpulse: Phase III started

Bellerophon began the double-blind, placebo-controlled, international Phase III INOvation-1 trial to evaluate 15 and 75 ug/kg per hour

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE